Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Should You Buy?

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $3.81, but opened at $4.0510. Hypermarcas shares last traded at $4.0510, with a volume of 8,913 shares.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Buy”.

Get Hypermarcas alerts:

Check Out Our Latest Analysis on Hypermarcas

Hypermarcas Trading Up 0.3%

The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27. The company’s 50 day moving average is $4.44 and its 200 day moving average is $4.42. The stock has a market capitalization of $2.76 billion, a price-to-earnings ratio of 8.17 and a beta of 0.70.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. The company had revenue of $383.13 million for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. On average, research analysts forecast that Hypermarcas will post 0.53 EPS for the current fiscal year.

Hypermarcas Company Profile

(Get Free Report)

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.

See Also

• Five stocks we like better than Hypermarcas
• Top Consumer Discretionary Brands Add Buyback Capacity Amid Weakness
• Micron’s Sudden Plunge May Be an AI Buying Chance
• As Inflation Hits 3-Year High, These 2 ETFs Are Designed to Hedge Against Rising Costs
• BitMine’s Ethereum Bet Is Only Part of the Story

Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.